Syntol-AMD
Natural health product licensed in Canada
- Other names
- Kyra, Spectra 12
- Licence holder
- Arthur Andrew Medical Inc.
- NPN or DIN-HM
- 80041078
- Status
- Active licence
- Licence date
- 18 March 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- À vérifier
Serratiopeptidase is listed in the Novel Food Catalogue as a novel food not yet authorised in the European Union: in the form covered by the entry, it should not be sold until authorised. The catalogue is informative; a declaration in France is not an authorisation.
POL-NF-00692. Novel Food Catalogue (status of products under Regulation (EU) 2015/2283), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lactobacillus rhamnosus Source : ATCC SD5217 | 500 Millions d'UFC | Not calculated |
| Lactobacillus rhamnosus Source : Cellule entière | 500 Millions d'UFC | Not calculated |
| Lactobacillus acidophilus Source : Cellule entière | 500 Millions d'UFC | Not calculated |
| Lactobacillus acidophilus Source : ATCC SD5212 | 500 Millions d'UFC | Not calculated |
| Lactobacillus plantarum Source : Cellule entière | 500 Millions d'UFC | Not calculated |
| Lactobacillus plantarum Source : ATCC SD5209 | 500 Millions d'UFC | Not calculated |
| Lactobacillus helveticus Source : (DSL listed) | 500 Millions d'UFC | Not calculated |
| Lactobacillus helveticus Source : Cellule entière | 500 Millions d'UFC | Not calculated |
| Lactobacillus helveticus Source : Strain # 6051A | 500 Millions d'UFC | Not calculated |
| Bifidobacterium bifidum Source : ATCC SD5215 | 75 Millions d'UFC | Not calculated |
| Bifidobacterium bifidum Source : Cellule entière | 75 Millions d'UFC | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma reesei | 27,500 FCC CU | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma reesei | 198.57 mg | Not calculated |
| Serratiopeptidase Source : Serratia marcescens (E-15) | 1,500 FCC SU | Not calculated |
| Serratiopeptidase Source : Serratia marcescens (E-15) | 0.65 mg | Not calculated |
| Saccharomyces boulardii Source : Cellule entière | 75 Millions d'UFC | Not calculated |
Non-medicinal ingredients
cellulose, Palmitate d'ascorbyle, Isomaltooligosaccharides
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Provides live microorganisms that temporarily modify gut flora. Probiotics that temporarily modify gut flora. Source of probiotics. Digestive aid. Digestive enzyme. Protease helps digest proteins.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80041078
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.